The Congress will bring together sickle cell diseases (SCD) stakeholders from various sectors, including clinicians, scientists, patients, health policy makers and advocacy groups to catalyze discussion around the achievements and challenges in the diagnosis, treatment and care of people living with SCD globally, as well as the prospects for further progress.
Sickle cell disease is one the world’s most prevalent genetic diseases. Major advances have been made in understanding the disease, paving the way for new and effective treatments. Neonatal screening is developing in many countries, resulting in early prevention of infections and improved parental education. New preventive treatments for vaso-occlusive crises and chronic anemia are now available.
Date:
June 16-18, 2022
Location:
Novotel Paris Tour Eiffel
61 Quai de Grenelle
Paris, France
This event has ended.